Literature DB >> 2469016

Rubber anaphylaxis.

J E Slater1.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2469016     DOI： 10.1056/NEJM198904273201707

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  17 in total

1.  Prevalence and risk factors for latex allergy: a cross sectional study in a United Kingdom hospital.

Authors:  J Smedley; A Jury; H Bendall; A Frew; D Coggon
Journal:  Occup Environ Med       Date:  1999-12       Impact factor: 4.402

2.  Latex allergy.

Authors:  M E Weiss; C A Hirshman
Journal:  Can J Anaesth       Date:  1992-07       Impact factor: 5.063

3.  Anaesthesia and the patient with latex allergy.

Authors:  L J McKinstry; W J Fenton; P Barrett
Journal:  Can J Anaesth       Date:  1992-07       Impact factor: 5.063

Review 4.  Management of anaphylactic and anaphylactoid reactions during anesthesia.

Authors:  B Eon; L Papazian; F Gouin
Journal:  Clin Rev Allergy       Date:  1991 Fall-Winter

Review 5.  Allergy to latex.

Authors:  F Leynadier; J Dry
Journal:  Clin Rev Allergy       Date:  1991 Fall-Winter

Review 6.  Pathophysiological and clinical aspects of immediate hypersensitivity to latex.

Authors:  F Leynadier
Journal:  Clin Rev Allergy       Date:  1993

Review 7.  Intraoperative anaphylaxis to latex.

Authors:  J Swartz; B M Braude; R F Gilmour; B Shandling; M Gold
Journal:  Can J Anaesth       Date:  1990-07       Impact factor: 5.063

8.  Treatment with isoproterenol of bupivacaine toxicity.

Authors:  P Lacombe; G Blaise; F Plante; C Hollmann
Journal:  Can J Anaesth       Date:  1990-05       Impact factor: 5.063

9.  An unusual presentation of latex allergy.

Authors:  O Opsomer; M Van Boven; P Pendeville; F Veyckemans
Journal:  Can J Anaesth       Date:  1993-10       Impact factor: 5.063

10.  Induction of mucosal tolerance with recombinant Hev b 1 and recombinant Hev b 3 for prevention of latex allergy in BALB/c mice.

Authors:  K Hufnagl; B Wagner; B Winkler; K Baier; R Hochreiter; J Thalhamer; D Kraft; O Scheiner; H Breiteneder; U Wiedermann
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.